HMGN (Hemagen Diagnostics) LT-Debt-to-Total-Asset: 1.66 (As of Sep. 2012)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hemagen Diagnostics LT-Debt-to-Total-Asset?

Hemagen Diagnostics HMGN LT-Debt-to-Total-Asset is 1.66 as of Sep. 2012.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Hemagen Diagnostics's long-term debt to total assests ratio for the quarter that ended in Sep. 2012 was 1.66.

Hemagen Diagnostics's long-term debt to total assets ratio increased from Sep. 2011 (1.40) to Sep. 2012 (1.66). It may suggest that Hemagen Diagnostics is progressively becoming more dependent on debt to grow their business.

Hemagen Diagnostics  (OTCPK:HMGN) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Hemagen Diagnostics LT-Debt-to-Total-Asset Related Terms

Hemagen Diagnostics LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Hemagen Diagnostics's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hemagen Diagnostics LT-Debt-to-Total-Asset Chart

Hemagen Diagnostics Annual Data
Trend Sep03 Sep04 Sep05 Sep06 Sep07 Sep08 Sep09 Sep10 Sep11 Sep12
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 1.09 1.20 1.40 1.66

Hemagen Diagnostics Quarterly Data
Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.40 1.57 1.56 1.61 1.66

Hemagen Diagnostics LT-Debt-to-Total-Asset Calculation

Hemagen Diagnostics's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Sep. 2012 is calculated as

LT Debt to Total Assets (A: Sep. 2012 )=Long-Term Debt & Capital Lease Obligation (A: Sep. 2012 )/Total Assets (A: Sep. 2012 )
=4.05/2.443
=1.66

Hemagen Diagnostics's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2012 is calculated as

LT Debt to Total Assets (Q: Sep. 2012 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2012 )/Total Assets (Q: Sep. 2012 )
=4.05/2.443
=1.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 1.66 mean?
Hemagen Diagnostics (HMGN) has a LT-Debt-to-Total-Asset of 1.66 as of Sep. 2012. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Hemagen Diagnostics and its competitors.
Is Hemagen Diagnostics' LT-Debt-to-Total-Asset too high?
Hemagen Diagnostics' current LT-Debt-to-Total-Asset is 1.66.
How does Hemagen Diagnostics' LT-Debt-to-Total-Asset compare to OBMP and NSPX?
Hemagen Diagnostics' LT-Debt-to-Total-Asset of 1.66 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Biotechnology company?
A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Hemagen Diagnostics and its competitors. Hemagen Diagnostics's current LT-Debt-to-Total-Asset is 1.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemagen Diagnostics stock overvalued right now?
Hemagen Diagnostics (HMGN) has a current LT-Debt-to-Total-Asset of 1.66. The current LT-Debt-to-Total-Asset is 1.66. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Hemagen Diagnostics (HMGN), the current LT-Debt-to-Total-Asset is 1.66 as of Sep. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hemagen Diagnostics Business Description

Address 9033 Red Branch Road, Columbia, MD, USA, 21045
Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.